During a live event, Naresh Bumma, MD, discussed CRS, oral and skin toxicities, and low discontinuation rates with ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

RAPID CITY, S.D. (KELO) — Multiple Myeloma is a blood cancer where plasma cells crowd out normal blood cells in the bone marrow. This can lead to ... I’ve even put my foot on the floor ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard reveals how multiple myeloma, a form of blood cancer, begins and ...

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of ...

Multiple myeloma is a disease that most people haven’t heard of until it impacts their lives directly. This blood cancer can sound daunting but understanding it is the first step towards ...

In multiple myeloma, abnormal plasma cells build up inside ... and the area is then covered with a pressure dressing. Will it hurt? It can be uncomfortable, but individual patient experiences ...

In the evolving landscape of haematologic cancers, the concept of minimal residual disease, also known as measurable residual ...

4 Over time, treatments have become more effective at reducing the disease burden of multiple myeloma, but challenges remain. Even when there is no detectable disease, relapse can occur years ...